$113.00
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Country

US

CEO

Dr. Prahlad Singh

IPO date

1965

Employees

11,000

ISIN

US7140461093

Key stats

Open

$113.00

Volume

1.61M

Market cap

$12.20B

Prev. close

$112.95

Impl / hst vl

-

Open interest

$0.00

$113.00

Day’s Range

$113.00

$81.22

52W Range

$118.30

Valuation

44
Valuation score
Fairly Valued
P/E
50.62
P/S
4.18
P/B
1.69
Current ratio
1.72
Debt / Equity
0.33
ROE
3.26%
Gross margin
54.51%
Income growth
-58.60%
FCF growth
-41.00

Aug

7

Dividends

The next payment date will be Aug 7, 2026

Div. per Share

$0.07

Div. Yield

0.06%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 12 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$118.00
The top 19 analysts forecasts that 12-month price may increase by 4.43%, with a low of $101.00 and a high of $152.25
$101.00
Low
$118.00
Avg
$152.25
High
Current price

Earnings

Q2 ‘26 revenue
$711.12M
Q2 ‘26 net income
$40.72M
Revenue
Net income
Previous EPS
$1.06
Estimate EPS
$1.25
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply